Singapore markets closed

SymBio Pharmaceuticals Limited (4582.T)

Tokyo - Tokyo Delayed price. Currency in JPY
Add to watchlist
160.00-1.00 (-0.62%)
At close: 03:15PM JST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-2,744,669
-1,962,817
1,179,238
2,032,203
-4,090,216
Depreciation & amortisation
-
96,005
98,092
93,959
63,835
Stock-based compensation
-
82,497
104,731
124,270
102,378
Change in working capital
-
841,041
-59,781
-1,066,669
-228,531
Inventory
-
237,277
-82,746
559,235
-944,442
Other working capital
-
-427,482
1,566,683
76,205
-4,271,414
Other non-cash items
-
-88,418
155,019
13,906
-457,692
Net cash provided by operating activities
-
-194,685
1,614,241
140,042
-4,122,483
Cash flows from investing activities
Investments in property, plant and equipment
-
-232,797
-47,558
-63,837
-148,931
Other investing activities
-
-143,899
431
-7,012
-11,378
Net cash used for investing activities
-
-376,696
-47,127
-70,849
-160,309
Net change in cash
-
234,452
2,408,809
11,480
-62,203
Cash at beginning of period
-
6,282,554
3,860,106
3,848,626
3,910,830
Cash at end of period
-
6,517,007
6,282,554
3,860,106
3,848,626
Free cash flow
Operating cash flow
-
-194,685
1,614,241
140,042
-4,122,483
Capital expenditure
-
-232,797
-47,558
-63,837
-148,931
Free cash flow
-
-427,482
1,566,683
76,205
-4,271,414